Menarini Group And Nippon Shinyaku Enter Into An Exclusive License Agreement To Develop And Commercialize Elzonris® (Tagraxofusp) In Japan

FLORENCE, ITALY March 29th, 2021 – The Menarini Group announced today that it has entered into an exclusive license agreement for the development and commercialization of ELZONRIS® (tagraxofusp) in the territory of Japan with Nippon Shinyaku Co.,...
Read More